Inactive Instrument

Other languages Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

Sumitovant Biopharma Ltd. completed the acquisition of remaining 47.83% stake in Myovant Sciences Ltd..	23-03-09
Myovant Sciences Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-01-26
Insider Sell: Myovant Sciences	23-01-20
Myovant Sciences Appoints Ann Tomlin as Senior Vice President of Human Resources	22-11-16
Myovant Sciences Fiscal Q2 Loss Widens, Revenue Rises	22-10-26
Myovant Sciences Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-10-26
Buying Spree Pulls Up Japanese Stocks; Sumitomo Pharma Unit to Buy Remaining 48% of Myovant Sciences for $1.7 Billion	22-10-25
Myovant Sciences Share Rise After Agreement to be Fully Acquired by Sumitovant Biopharma	22-10-24
Myovant Sciences to be Fully Acquired by Sumitovant Biopharma	22-10-24
Myovant Sciences Ltd. Appoints Shigeyuki Nishinaka as Director	22-10-21
Insider Sell: Myovant Sciences	22-10-20
Sector Update: Health Care Stocks Catching Up With Broader Market Gains	22-10-03
Sector Update: Health Care Stocks Mostly Higher in Afternoon Trading	22-10-03
Myovant Sciences Rejects Go-Private Offer From Sumitovant Biopharma, Citing Valuation Concerns	22-10-03
Sector Update: Health Care Stocks Edge Higher Premarket Monday	22-10-03
Bolsa de Madrid: Bye-bye Septiembre	22-10-03
Bye-bye Septembre	22-10-03
EN DIRECT DES MARCHES : Stellantis, Société Générale, Unibail, Technip Energies, Bonduelle, Crédit Suisse, RWE, Tesla	22-10-03
Myovant Sciences rejects $2.5 bln takeover bid from Sumitovant, Sumitomo Pharma	22-10-02
Sumitovant Biopharma, Sumitomo Pharma submit offer to buy Myovant Sciences in $2.5 billion deal	22-10-02

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages Myovant Sciences Ltd.

Equities

MYOV

BMG637AM1024

Other languages

Filters